Life ScienceCompany
Five Prime Therapeutics Ownership
Who owns Five Prime Therapeutics?
Five Prime Therapeutics is owned by Amgen. It was acquired on March 4, 2021.
Was Five Prime Therapeutics formerly PE-backed?
Yes. Five Prime Therapeutics was formerly owned by 1 private investor.
Five Prime Therapeutics Business Overview
Where is Five Prime Therapeutics headquartered?
Five Prime Therapeutics is headquartered in South San Francisco, California.
What is Five Prime Therapeutics’ revenue?
Five Prime Therapeutics disclosed revenue of 15M USD for 2019 and 50M USD for 2018.
How many employees does Five Prime Therapeutics have?
Five Prime Therapeutics has 87 employees.
What sector is Five Prime Therapeutics in?
Five Prime Therapeutics is a life science company.
When was Five Prime Therapeutics founded?
Five Prime Therapeutics was founded in 2001.
Life Science M&A Summary in 2021
Out of 60 sectors in the Mergr database, life science ranked 7 in number of deals in 2021. The largest life science acquisition in 2021 was Pharmaceutical Product Development - which was acquired by Thermo Fisher Scientific for $17.4B.
Join Mergr to view all 391 acquisitions of life science companies in 2021, including 46 acquisitions by private equity firms, and 345 by strategics.